Session(s)
- When to Use Parenteral Prostacyclins?
Friday, May 18 2:30 PM - 3:00 PM - Noninvasive Assessment of Pulmonary Arterial Compliance in End-Stage Liver Disease [Board ...
Sunday, May 20 9:15 AM - 11:15 AM - Moderator
Sunday, May 20 2:15 PM - 4:15 PM - Leptin and Leptin Receptor in PAH and the Right Ventricle
Sunday, May 20 3:00 PM - 3:15 PM - Insulin Resistance, Diabetes and Pulmonary Hypertension
Monday, May 21 2:20 PM - 2:35 PM - Baseline and Demographic Data on the First 250 Patients from SPHERE (UptraviĀ® [SelexiPag]:...
Tuesday, May 22 11:15 AM - 1:00 PM - Rationale and Design of TRACE: A Double-Blind, Placebo-Controlled Phase 4 Study in Pulmona...
Tuesday, May 22 11:15 AM - 1:00 PM - Transitions from Inhaled, Intravenous, Subcutaneous, or Oral Prostacyclins to Selexipag: I...
Tuesday, May 22 11:15 AM - 1:00 PM - Metformin for End-Stage PAH (RV)
Tuesday, May 22 2:35 PM - 2:55 PM - Real-World Dosing and Titration of Selexipag in Patients with Pulmonary Arterial Hypertens...
Wednesday, May 23 1:30 PM - 3:30 PM